Manual for Trainers and Programme Managers
Download these technical notes directly from the website: These four-page illustrated notes, originally prepared in 2011 and updated in 2013, provide practical, evidence-based recommendations in responding to immediate and medium-term water, sanitation and hygiene needs of populations affected by e...mergencies.
The notes are relevant to a wide range or emergency situations, including both natural and conflict-induced disasters. They are suitable for field technicians, engineers and hygiene promotors, as well as staff from agency headquarters.
more
This leaflet aims at guiding health workers though the very first days of an outbreak. It addresses the following questions:
Is this the beginning of an outbreak?
Is the patient suffering from cholera or shigella?
The leaflet also has sections on how to protect the community, how to t...reat patients and what to do if an outbreak is suspected.
more
This leaflet aims at guiding health workers though the very first days of an outbreak. It addresses the following questions:
Is this the beginning of an outbreak?
Is the patient suffering from cholera or shigella?
The leaflet also has sections on how to protect the community, how to t...reat patients and what to do if an outbreak is suspected.
more
Patient Safety tutorial 325
On trouvera résumée ici la position actuelle du
Département Santé mentale et toxicomanies
concernant l’aide à apporter aux populations exposées
à des facteurs de stress extrême, par exemple réfugiés,
personnes déplacées dans leur propre pays, survivants
d’une catastrophe ou popu...lations exposées à des actes
de guerre ou à un génocide.
more
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...ren, and HIV co-infection are all fully addressed.
more
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...d with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
more